BreviTest has been broadly recognized for its exceptional technology and promising impact in the medical field.
BreviTest has won Small Business Innovation Research Grants (SBIR) from the National institute on Drug Abuse (2016) and Department of Health and Human Services (2017)
Texas New Ventures Prize winner
In 2015, Brevitest was awarded a prize at the inaugural Texas New Ventures Competition (TNVC) sponsored by Texas A&M University. BreviTest was selected for a prize form a group of 91 eligible contestants and was recognized for its potential global impact in the medical field.
BreviTest (far left) was named a semi-finalist in the AACC’s first ever disruptive technology competition. Being a semi-finalist BreviTest was asked to present as a keynote technology at the 70th annual clinical lab expo in Chicago. This technology exposition is the largest in the world for clinical laboratory products and services, and included over 860 presenting companies.